[Comparison among measures to prevent intrauterine adhesions after artificial abortion].
Li, Lei; Nai, Manman; Gao, Guixiang; Wang, Luwen.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 41(9): 975-8, 2016 Sep 28.
Artigo em Chinês | MEDLINE | ID: mdl-27640797
Observation of clinical efficacy of yousiyue for endometrium regeneration after superconducting visual abortion and its nursing.
Clinical experiences with drospirenone: from reproductive to postmenopausal years.
Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.
Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old.
Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer.
Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes.
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.